1. Home
  2. GOCO vs HOWL Comparison

GOCO vs HOWL Comparison

Compare GOCO & HOWL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GOCO
  • HOWL
  • Stock Information
  • Founded
  • GOCO 2001
  • HOWL 2017
  • Country
  • GOCO United States
  • HOWL United States
  • Employees
  • GOCO N/A
  • HOWL N/A
  • Industry
  • GOCO Specialty Insurers
  • HOWL Biotechnology: Pharmaceutical Preparations
  • Sector
  • GOCO Finance
  • HOWL Health Care
  • Exchange
  • GOCO Nasdaq
  • HOWL Nasdaq
  • Market Cap
  • GOCO 64.9M
  • HOWL 64.5M
  • IPO Year
  • GOCO 2020
  • HOWL 2021
  • Fundamental
  • Price
  • GOCO $4.33
  • HOWL $1.64
  • Analyst Decision
  • GOCO Hold
  • HOWL Strong Buy
  • Analyst Count
  • GOCO 1
  • HOWL 5
  • Target Price
  • GOCO $12.00
  • HOWL $7.20
  • AVG Volume (30 Days)
  • GOCO 43.5K
  • HOWL 1.6M
  • Earning Date
  • GOCO 11-06-2025
  • HOWL 11-06-2025
  • Dividend Yield
  • GOCO N/A
  • HOWL N/A
  • EPS Growth
  • GOCO N/A
  • HOWL N/A
  • EPS
  • GOCO N/A
  • HOWL N/A
  • Revenue
  • GOCO $822,444,000.00
  • HOWL N/A
  • Revenue This Year
  • GOCO $2.06
  • HOWL N/A
  • Revenue Next Year
  • GOCO $5.47
  • HOWL N/A
  • P/E Ratio
  • GOCO N/A
  • HOWL N/A
  • Revenue Growth
  • GOCO 17.46
  • HOWL N/A
  • 52 Week Low
  • GOCO $4.31
  • HOWL $0.60
  • 52 Week High
  • GOCO $21.00
  • HOWL $4.18
  • Technical
  • Relative Strength Index (RSI)
  • GOCO 35.18
  • HOWL 49.70
  • Support Level
  • GOCO $4.32
  • HOWL $1.92
  • Resistance Level
  • GOCO $4.97
  • HOWL $2.13
  • Average True Range (ATR)
  • GOCO 0.26
  • HOWL 0.21
  • MACD
  • GOCO -0.00
  • HOWL -0.02
  • Stochastic Oscillator
  • GOCO 3.75
  • HOWL 27.71

About GOCO GoHealth Inc.

GoHealth Inc is a health insurance marketplace and Medicare-focused digital health company whose purpose is to compassionately ensure consumers' peace of mind when making healthcare decisions so consumers can focus on living life. It offers Medicare plans, including, but not limited to, Medicare Advantage, Medicare Supplement and prescription drug plans. Its proprietary technology platform leverages modern machine-learning algorithms, powered by over two decades of insurance purchasing behavior, to reimagine the process of matching a health plan to a consumer's specific needs.

About HOWL Werewolf Therapeutics Inc.

Werewolf Therapeutics Inc is a biopharmaceutical company pioneering the development of therapeutics engineered to stimulate the body's immune system for the treatment of cancer. It is leveraging its proprietary PREDATOR platform to design conditionally activated molecules that stimulate both adaptive and innate immunity with the goal of addressing the limitations of conventional proinflammatory immune therapies. Its INDUKINE molecules are intended to remain inactive in peripheral tissue yet activate selectively in the tumor microenvironment or TME.

Share on Social Networks: